Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care.

[1]  N. O'Rourke,et al.  Concurrent chemoradiotherapy in non-small cell lung cancer. , 2010, The Cochrane database of systematic reviews.

[2]  Dianne L. O’Connell,et al.  Gaps in Optimal Care for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  A. Price,et al.  Improved Treatment and Survival for Lung Cancer Patients in South-East Scotland , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  M. Kris,et al.  Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  W Michael Alberts,et al.  Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). , 2007, Chest.

[6]  L. Seymour,et al.  Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Møller,et al.  Variation in the use of chemotherapy in lung cancer , 2007, British Journal of Cancer.

[8]  J. Luketich,et al.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. , 2006, The Annals of thoracic surgery.

[9]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[10]  R. V. van Klaveren,et al.  Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. , 2005, The Annals of thoracic surgery.

[11]  J. Whang‐Peng,et al.  Chemotherapy for non-small cell lung cancer in elderly patients. , 2005, Chest.

[12]  Y. Shim,et al.  Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  M. Adachi,et al.  Patients preferences in chemotherapy for advanced non-small-cell lung cancer. , 2005, Internal medicine.

[14]  C. Belchamber.  The Diagnosis and Treatment of Lung Cancer: Methods, evidence and guidance , 2005 .

[15]  J. V. van Dijck,et al.  Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. , 2004, Lung cancer.

[16]  K. Matsuo,et al.  Role of Adjuvant Chemotherapy in Patients With Resected Non-Small-Cell Lung Cancer: Reappraisal With a Meta-analysis of Randomized Controlled Trials , 2006 .

[17]  R. Souhami,et al.  Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life , 2004, Thorax.

[18]  W. Otten,et al.  Review of determinants of patients' preferences for adjuvant therapy in cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Coebergh,et al.  Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer , 2004, Thorax.

[20]  Thomas J. Smith,et al.  American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Bauman,et al.  Efficacy of pneumococcal vaccine , 2003, Thorax.

[22]  H. Comber,et al.  Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. , 2003, Lung cancer.

[23]  G. Pelosi,et al.  Late events and clinical prognostic factors in stage I non small cell lung cancer. , 2002, Lung cancer.

[24]  W. Curran,et al.  Do elderly patients (pts) with locally advanced non-small cell lung cancer (NSCLC) benefit from combined modality therapy? a secondary analysis of RTOG 94-10 , 2001 .

[25]  A. Gregor,et al.  Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study , 2001, Thorax.

[26]  M. Weinstein,et al.  Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  G. Giles,et al.  Reported management of lung cancer in Victoria in 1993: comparison with best practice , 2000, Medical Journal of Australia.

[28]  J. Piccirillo,et al.  Importance of Comorbidity in Head and Neck Cancer , 2000, The Laryngoscope.

[29]  T. Ohno,et al.  Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. , 1999, Lung cancer.

[30]  H. Welch,et al.  Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.

[31]  J. Coebergh,et al.  Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. , 1998, Lung cancer.

[32]  M. Hareyama,et al.  Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer. , 1998, Lung cancer.

[33]  B. Jeremic,et al.  Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. , 1997, International journal of radiation oncology, biology, physics.

[34]  B. Jeremic,et al.  Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  H. Kreisman,et al.  Treatment of small cell lung carcinoma in the elderly , 1996, Cancer.

[36]  D. Winchester,et al.  The National Cancer Data Base report on lung cancer , 1996, Cancer.

[37]  E. Noordijk,et al.  Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? , 1996, International journal of radiation oncology, biology, physics.

[38]  D. Harpole,et al.  Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence , 1995, Cancer.

[39]  S. Hogg-Johnson,et al.  Treatment of Small Cell Lung Cancer in the Elderly , 1994, Journal of the American Geriatrics Society.

[40]  W. Yin,et al.  Curative radiotherapy of early operable non-small cell lung cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  E. Bergstralh,et al.  Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. , 1984, The Annals of thoracic surgery.

[42]  P. Lambin,et al.  Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  Dl Ball,et al.  Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer , 2004 .

[44]  M. Anscher,et al.  Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. , 1998, International journal of radiation oncology, biology, physics.

[45]  M E Burt,et al.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.